000 01719 a2200481 4500
005 20250514232450.0
264 0 _c20060531
008 200605s 0 0 eng d
022 _a0302-2838
024 7 _a10.1016/j.eururo.2005.04.011
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRiedl, Claus R
245 0 0 _aLiposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study.
_h[electronic resource]
260 _bEuropean urology
_cOct 2005
300 _a656-61 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aCross-Over Studies
650 0 4 _aDisease Progression
650 0 4 _aDouble-Blind Method
650 0 4 _aDupuytren Contracture
_xdrug therapy
650 0 4 _aFree Radical Scavengers
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLiposomes
650 0 4 _aMale
650 0 4 _aPain Measurement
650 0 4 _aPatient Satisfaction
650 0 4 _aPenile Erection
_xdrug effects
650 0 4 _aPenile Induration
_xdrug therapy
650 0 4 _aProspective Studies
650 0 4 _aSuperoxide Dismutase
_xadministration & dosage
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aSternig, Peter
700 1 _aGallé, Günter
700 1 _aLangmann, Florian
700 1 _aVcelar, Brigitta
700 1 _aVorauer, Karola
700 1 _aWagner, Andreas
700 1 _aKatinger, Hermann
700 1 _aPflüger, Heinz
773 0 _tEuropean urology
_gvol. 48
_gno. 4
_gp. 656-61
856 4 0 _uhttps://doi.org/10.1016/j.eururo.2005.04.011
_zAvailable from publisher's website
999 _c15640296
_d15640296